These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes. Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442 [TBL] [Abstract][Full Text] [Related]
5. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner. Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944 [TBL] [Abstract][Full Text] [Related]
6. Activation of lymphotoxin-beta receptor enhances the LPS-induced expression of IL-8 through NF-κB and IRF-1. Jang SW; Lim SG; Suk K; Lee WH Immunol Lett; 2015 Jun; 165(2):63-9. PubMed ID: 25887375 [TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin β receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFα and IL-1β in bladder cancer cells. Shen M; Zhou L; Zhou P; Zhou W; Lin X Mol Med Rep; 2017 Jul; 16(1):937-942. PubMed ID: 28586003 [TBL] [Abstract][Full Text] [Related]
8. The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization. Liu HP; Chung PJ; Liang CL; Chang YS Cell Signal; 2011 Jan; 23(1):80-8. PubMed ID: 20732415 [TBL] [Abstract][Full Text] [Related]
9. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Guedj K; Khallou-Laschet J; Clement M; Morvan M; Gaston AT; Fornasa G; Dai J; Gervais-Taurel M; Eberl G; Michel JB; Caligiuri G; Nicoletti A Cardiovasc Res; 2014 Mar; 101(3):434-43. PubMed ID: 24272771 [TBL] [Abstract][Full Text] [Related]
10. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3. You RI; Chen MC; Wang HW; Chou YC; Lin CH; Hsieh SL Cancer Res; 2006 Mar; 66(6):3051-61. PubMed ID: 16540654 [TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. Madge LA; Kluger MS; Orange JS; May MJ J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573 [TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021 [TBL] [Abstract][Full Text] [Related]
14. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937 [TBL] [Abstract][Full Text] [Related]
15. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229 [TBL] [Abstract][Full Text] [Related]
16. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells. Hehlgans T; Müller P; Stopfer P; Männel DN Eur Cytokine Netw; 2003; 14(2):103-7. PubMed ID: 12957791 [TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells. Stopfer P; Männel DN; Hehlgans T J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124 [TBL] [Abstract][Full Text] [Related]
18. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation. Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497 [TBL] [Abstract][Full Text] [Related]
19. Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-stimulated and -unstimulated macrophages. D'Este F; Tomasinsig L; Skerlavaj B; Zanetti M Immunobiology; 2012 Oct; 217(10):962-71. PubMed ID: 22317752 [TBL] [Abstract][Full Text] [Related]
20. Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands. Barabas N; Röhrl J; Holler E; Hehlgans T Immunobiology; 2013 Jul; 218(7):1005-11. PubMed ID: 23332217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]